Trading (RGEN) With Integrated Risk Controls - news.stocktradersdaily.com
Yesterday • Google News
Repligen Corporation (RGEN)
US$ 144.75-0.33%
Price Chart
Key Statistics
Market Cap
$ 7.08B
P/E Ratio
0.00
Revenue (TTM)
$ 650.43M
Volume
434.86K
52W High
$ 182.52
52W Low
$ 102.97
Dividend Yield
0.00%
Beta
1.11
Technicals
50-Day MA
128.4128
200-Day MA
142.4778
52 Week High
182.52
52 Week Low
102.965
About RGEN
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A l.
Employees
1778
Headquarters
Waltham, MA
CEO
Mr. Anthony J. Hunt
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg